Page last updated: 2024-10-25

cilostazol and Anterior Compartment Syndrome

cilostazol has been researched along with Anterior Compartment Syndrome in 1 studies

Anterior Compartment Syndrome: Rapid swelling, increased tension, pain, and ischemic necrosis of the muscles of the anterior tibial compartment of the leg, often following excessive PHYSICAL EXERTION.

Research Excerpts

ExcerptRelevanceReference
"Cilostazol inhibits the increase in compartment pressure central to the development of the compartment syndrome."1.30Selective type III phosphodiesterase inhibition prevents elevated compartment pressure after ischemia/reperfusion injury. ( Cunningham, L; Hakaim, AG; Hoover, K; White, JL, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hakaim, AG1
Cunningham, L1
White, JL1
Hoover, K1

Other Studies

1 other study available for cilostazol and Anterior Compartment Syndrome

ArticleYear
Selective type III phosphodiesterase inhibition prevents elevated compartment pressure after ischemia/reperfusion injury.
    The Journal of trauma, 1999, Volume: 46, Issue:5

    Topics: Animals; Anterior Compartment Syndrome; Cilostazol; Hindlimb; Muscle, Skeletal; Oxygen Consumption;

1999